Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

10 terminated/withdrawn out of 60 trials

Success Rate

80.8%

-5.7% vs industry average

Late-Stage Pipeline

17%

10 trials in Phase 3/4

Results Transparency

31%

13 of 42 completed trials have results

Key Signals

6 recruiting13 with results7 terminated

Enrollment Performance

Analytics

N/A

40(78.4%)

Phase 3

6(11.8%)

Phase 4

4(7.8%)

Phase 2

1(2.0%)

51Total

N/A(40)

Phase 3(6)

Phase 4(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (60)

Showing 20 of 60 trials

NCT07539883Recruiting

Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study

Role: collaborator

NCT07539428Not ApplicableEnrolling By Invitation

Peritoneal Dialysis (PD) Specialized LLM for PD Management

Role: collaborator

NCT06983509Completed

Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy

Role: lead

NCT06492031Completed

Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients

Role: lead

NCT05399537Phase 3Recruiting

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Role: lead

NCT07262320Recruiting

Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America

Role: collaborator

NCT07419802Recruiting

OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study

Role: collaborator

NCT06633029Completed

Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry

Role: lead

NCT07326215Not ApplicableRecruiting

A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+

Role: lead

NCT01413074Not ApplicableTerminated

Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China

Role: lead

NCT07334327Not ApplicableNot Yet Recruiting

Extracorporeal Blood Purification Using Oxiris for Septic Shock (EXPLORE Study)

Role: collaborator

NCT04617093Not ApplicableCompleted

Post-Market Study of Low-flow ECCO2R Using PrismaLung+

Role: lead

NCT05018221Phase 3Recruiting

Better Evidence and Translation for Calciphylaxis

Role: collaborator

NCT00962000Not ApplicableCompleted

Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate

Role: lead

NCT01219959Phase 3Completed

Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

Role: lead

NCT00659724Completed

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

Role: lead

NCT02860130Phase 3Terminated

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Role: lead

NCT00567398Phase 3Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Role: lead

NCT00567489Phase 4Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Role: lead

NCT00368641Phase 2Terminated

Heart Failure and Peritoneal Ultrafiltration

Role: lead